Condition
Amyloidosis Transthyretin clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Amyloidosis Transthyretin clinical trials that are recruiting, at sites in 2 countries (most in Brazil (1), France (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Using tiny blood particles to detect and track ATTR heart amyloidosis
This project will test whether tiny blood particles called extracellular vesicles can help detect and track transthyretin (ATTR) amyloid cardiomyopathy in people with or at risk for ATTR.
-
Analyzing Heart Uptake of Bone Medications in Patients with Cardiac Amyloidosis
This study is testing how well certain bone medications are taken up by the heart in patients with cardiac amyloidosis to see if it can help improve their diagnosis and treatment.
Related topics
Quick answers
How many Amyloidosis Transthyretin clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Brazil (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.